RecruitingNCT07167433

Observational, Bi-directional (Prospective and Retrospective) Study for Patients With Newly Diagnosed Ovarian Cancer Stages IA to IVB, or Persistent or Recurrent Disease From January 2021; Irrespective of Histology

Ovarian Cancer Epidemiology and Care in Brazil: A Multicenter Perspective (OLIVIA Study) Observational, Bi-directional (Prospective and Retrospective) Study for Patients With Newly Diagnosed Ovarian Cancer Stages IA to IVB, or Persistent or Recurrent Disease From January 2021; Irrespective of Histology


Sponsor

AstraZeneca

Enrollment

250 participants

Start Date

Sep 19, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The findings from this study have the potential to serve as a foundation for evaluating the current practices related to surgical procedures, systemic therapies, hyperthermic intraperitoneal chemotherapy, and referrals to geneticists for OC patients. By identifying the strengths and weaknesses of the existing care, this project intends to generate valuable insights that can lead to the implementation of quality parameters for the treatment of ovarian cancer in the country.


Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This is an observational study — no experimental treatment is involved. Researchers are collecting data on women diagnosed with ovarian cancer (any stage) since January 2021 to better understand how the disease is managed in the real world and what factors affect outcomes over time. **You may be eligible if...** - You are 18 years or older - You have been diagnosed with ovarian cancer (any stage, from stage IA to IVB) since January 2021, or have persistent or recurrent disease - Any type of ovarian cancer histology is accepted **You may NOT be eligible if...** - Your ovarian tumor is classified as borderline (not fully cancerous) - You are pregnant - You have had another cancer in the past 5 years (except thyroid cancer or non-melanoma skin cancer) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Research Site

Porto Alegre, Brazil

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07167433


Related Trials